S

Shanghai MicroPort MedBot Group Co Ltd
HKEX:2252

Watchlist Manager
Shanghai MicroPort MedBot Group Co Ltd
HKEX:2252
Watchlist
Price: 8.17 HKD -10.71% Market Closed
Market Cap: 7.9B HKD
Have any thoughts about
Shanghai MicroPort MedBot Group Co Ltd?
Write Note

Net Margin
Shanghai MicroPort MedBot Group Co Ltd

-480.3%
Current
-10 107%
Average
2.2%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-480.3%
=
Net Income
-750.3m
/
Revenue
156.2m

Net Margin Across Competitors

Country CN
Market Cap 7.8B HKD
Net Margin
-480%
Country US
Market Cap 204.9B USD
Net Margin
14%
Country US
Market Cap 195.2B USD
Net Margin
29%
Country US
Market Cap 146.7B USD
Net Margin
16%
Country US
Market Cap 132.6B USD
Net Margin
11%
Country IE
Market Cap 110.6B USD
Net Margin
12%
Country US
Market Cap 64.7B USD
Net Margin
9%
Country DE
Market Cap 55.6B EUR
Net Margin
8%
Country CN
Market Cap 319.2B CNY
Net Margin
34%
Country US
Market Cap 41.6B USD
Net Margin
74%
Country US
Market Cap 37.7B USD
Net Margin
9%
No Stocks Found

Shanghai MicroPort MedBot Group Co Ltd
Glance View

Market Cap
7.8B HKD
Industry
Health Care

Shanghai MicroPort MedBot (Group) Co., Ltd. operates as a surgical robot company dedicated to designing, developing and commercializing surgical robots to assist surgeons in performing complex surgical procedures. The company is headquartered in Shanghai, Shanghai and currently employs 756 full-time employees. The company went IPO on 2021-11-02. The firm's main business is the design, development and commercialization of innovative surgical robots. The firm's products include Toumai Laparoscopic Surgical Robot, DFVision 3D Electronic Laparoscope and Honghu Orthopedic Surgical Robot. The firm's surgical robots are used in multiple minimally invasive surgery fields, including endoscopic surgery, orthopedic surgery, pan-vascular surgery, natural cavity surgery and percutaneous puncture surgery. In addition, the Company also provides education and training services for its surgical robot MedBot.

Intrinsic Value
4.69 HKD
Overvaluation 43%
Intrinsic Value
Price
S

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-480.3%
=
Net Income
-750.3m
/
Revenue
156.2m
What is the Net Margin of Shanghai MicroPort MedBot Group Co Ltd?

Based on Shanghai MicroPort MedBot Group Co Ltd's most recent financial statements, the company has Net Margin of -480.3%.